Climb Bio (CLYM) Income from Non-Controlling Interests (2020 - 2022)

Climb Bio has reported Income from Non-Controlling Interests for 3 years, with the latest figure at -$13.6 million in Q1 2022.

• For the quarter ending Q1 2022, Income from Non-Controlling Interests rose 26.87% year-over-year to -$13.6 million; the trailing twelve-month figure through Mar 2022 stood at -$52.5 million (changed N/A YoY), and the FY2021 full-year result was -$47.6 million, down 130.32% from the prior year.
• Income from Non-Controlling Interests for Q1 2022 stood at -$13.6 million, down from -$10.6 million in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was -$2.3 million in Q3 2020, with the low at -$18.6 million in Q1 2021.
• Historically, Income from Non-Controlling Interests has averaged -$11.6 million across 3 years, with a median of -$12.1 million in 2021.
• The largest YoY upside for Income from Non-Controlling Interests was 28.35% in 2021 against a maximum downside of 326.62% in 2021.
• Climb Bio's Income from Non-Controlling Interests stood at -$14.9 million in 2020, then gained by 28.35% to -$10.6 million in 2021, then fell by 27.72% to -$13.6 million in 2022.
• The last three Income from Non-Controlling Interests figures came in at -$13.6 million (Q1 2022), -$10.6 million (Q4 2021), and -$9.6 million (Q3 2021), per Business Quant data.